Open-loop versus Closed-loop 3D Printing | The Lattice Brief (11-2-26)

blank blank Nov 02, 2026

This week in healthcare 3D printing: most printers record what they were told to do, not what happened, and that black box matters for FDA validation and for AI. Also: Materialise’s medical unit now drives more than half its revenue, Align pilots a directly printed sports guard, PharmaTher seeks FDA designations for a printed pediatric tablet, and new research on corneal bioprinting, printed zirconia crowns and a printed brain-cooling implant.

The big thing

Is your 3D printer a black box? Why we need closed-loop machines

A 3D printed implant can pass every inspection and still fail an audit. Most printers log their instructions, not what actually happened during the build.

Most printers are open loop, repeating one recipe every layer even as resin warms and light sources age. A closed-loop machine measures as it prints and corrects itself.

Few qualify. Stratasys’ Origin One and Intrepid Automation‘s projection printers market closed-loop control; Formlabs’ Form 4 is partly there. Most metal powder bed machines still only monitor.

Regulators care. FDA’s 2017 guidance on additive manufactured devices and the new Quality Management System Regulation expect validated processes. Patient-matched devices can’t be destructively tested, so the process record is the evidence.

So does AI. Layer-by-layer records could train printers to predict defects. A black box teaches nothing.

My view: buyers should demand open, machine-readable process records in every printer purchase.

Would you buy a printer that can’t show its work?

Read our full analysis →

From 3DHEALS

Regulatory watch

No new FDA 510(k) clearances for additively manufactured devices surfaced between Oct 18 and Nov 1.

  • PharmaTher files for FDA designations for 3D printed creatine tablets (VoxelMatters, Oct 30). PharmaTher asked FDA for Orphan Drug and Rare Pediatric Disease designations for a printed, dissolvable creatine mini-tablet for GAMT deficiency, a disorder with no approved therapy. One validated formulation can print several strengths. The company expects decisions and a pre-IND meeting in Q1 2027.

Clinical & research

Also this week

Industry and business

Design, quality and research

Prosthetics and funding

Next-Gen 3D Printed Orthotics and Prosthetics

Date change: We have moved the date of this webinar. It now takes place on Thursday, November 12, with Jade Ward (AMPrint Center, Rochester Institute of Technology) on additive manufacturing for low-resource settings and Tergel Bayarsaikhan (Rightfit) on AI-assisted orthotic design.

Register for Nov 12

Get The Lattice Brief every week: subscribe here.

Comments